Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

Renal Vitamins vs. Multivitamins for Kidney Disease Patients

Key Compositional Differences

  • Renal vitamins are specifically formulated for kidney disease patients with lower or absent fat-soluble vitamins to prevent toxicity, while containing adequate water-soluble vitamins to replace dialysis losses, making them the preferred choice over standard multivitamins for patients with CKD stages 3-5D, as recommended by the American Journal of Kidney Diseases 1
  • Vitamin A accumulates to toxic levels in kidney disease because retinol-binding protein is normally catabolized in renal tubules, according to the American Journal of Kidney Diseases 2, 3
  • Pediatric dialysis patients without supplementation show vitamin A levels 3-fold higher than controls, as reported by the American Journal of Kidney Diseases 3
  • Standard multivitamins containing vitamin A pose significant toxicity risk and should be avoided, as stated by the American Journal of Kidney Diseases 1
  • Vitamin E supplementation is not routinely recommended due to potential toxicity in dialysis patients, according to the American Journal of Kidney Diseases 1
  • Renal vitamins typically exclude vitamin K, particularly important for patients on anticoagulants like warfarin, as recommended by the American Journal of Kidney Diseases 1
  • Standard multivitamins often contain vitamin K which can interfere with anticoagulation therapy, as reported by the American Journal of Kidney Diseases 1

Water-Soluble Vitamins

  • Renal vitamins contain higher doses of water-soluble vitamins to compensate for dialysis losses, including thiamine, vitamin C, folate, and vitamin B6, as recommended by Clinical Nutrition 4, 5
  • Thiamine (B1) losses during dialysis are approximately 4 mg/day, and patients on continuous renal replacement therapy require 100-300 mg/day, according to Clinical Nutrition 4, 5
  • Vitamin C daily effluent losses are documented at 68 mg, and supplementation of at least 90 mg/d for men and 75 mg/d for women is recommended, but should not greatly exceed DRI due to oxalate accumulation risk, as stated by Clinical Nutrition and the American Journal of Kidney Diseases 4, 1, 3
  • Folate losses during dialysis are approximately 0.3 mg/day, as reported by Clinical Nutrition 4
  • Vitamin B6 deficiency is documented in 35.1% of hemodialysis patients, according to Clinical Nutrition 4

Electrolyte and Mineral Content

  • Renal formulas are more concentrated with lower electrolyte content, including reduced sodium, potassium, and phosphorus, to prevent hyperkalemia and hyperphosphatemia, as recommended by Clinical Nutrition 6
  • Standard multivitamins may contain excessive amounts of these electrolytes, worsening fluid and electrolyte imbalances, according to Clinical Nutrition 6
  • Moderate supplementation of zinc (50 mg/d) and selenium (75 mg/d) may not normalize levels in chronic hemodialysis patients, suggesting increased requirements, as reported by Clinical Nutrition 6, 4
  • Copper losses during continuous renal replacement therapy are significant, and 3 mg/d IV copper is suggested for patients on therapy >2 weeks, according to Clinical Nutrition 6, 4

Clinical Recommendations

  • The American Journal of Kidney Diseases recommends an individualized approach based on dietary intake assessment for CKD stages 3-4 patients, and consideration of renal-specific multivitamin if sustained inadequate dietary intake is documented 1
  • For CKD stage 5D patients, water-soluble vitamin supplementation should be routine, and renal vitamins are strongly preferred due to dialysis losses of water-soluble vitamins, as stated by the American Journal of Kidney Diseases 1
  • The most deficient micronutrients in hemodialysis patients are zinc (44.1%), thiamine (24.7%), and vitamin B6 (35.1%), according to Clinical Nutrition 4

Critical Safety Considerations

  • Excessive vitamin C intake (0.5-1 g/d) increases plasma and soft tissue oxalate concentrations, and combined dietary and supplement intake should not greatly exceed DRI, as reported by the American Journal of Kidney Diseases 2, 3
  • Vitamin D management requires separate consideration from multivitamin choice, and cholecalciferol or ergocalciferol supplementation should be based on 25(OH)D levels, as recommended by the American Journal of Kidney Diseases 1
  • Serum levels should guide supplementation when continuous renal replacement therapy exceeds 2 weeks, and copper levels are particularly important with prolonged dialysis, according to Clinical Nutrition 6, 4